Biostage, Inc. (BSTG) is a publicly traded company in the Healthcare sector, operating within the Biotechnology industry. The company is headquartered in Holliston, MA, United States. The current CEO is Junli He.
BSTG has IPO date of 2013-10-21, 7 full-time employees, listed on the Other OTC, a market capitalization of $57.82M.
Biostage, Inc., a biotechnology company, offers products to cure patients of cancers, injuries, and birth defects of the gastro-intestinal tract and the airways. The company is engaged in developing Biostage Esophageal Implant for the treating esophageal cancer. The company was formerly known as Harvard Apparatus Regenerative Technology, Inc. and changed its name to Biostage, Inc. in March 2016. Biostage, Inc. was founded in 2009 and is headquartered in Holliston, Massachusetts.
